141 related articles for article (PubMed ID: 38146568)
21. Male Breast Cancer: Clinical, Demographical, and Pathological Features in a Cohort of 41 Patients.
Koseci T; Haksöyler V; Olgun P; Koyuncu MB; Bozkurt Duman B; Çil T
Cureus; 2021 Sep; 13(9):e17812. PubMed ID: 34660022
[TBL] [Abstract][Full Text] [Related]
22. A Prognostic Analysis of Male Breast Cancer (MBC) Compared with Post-Menopausal Female Breast Cancer (FBC).
Yu XF; Yang HJ; Yu Y; Zou DH; Miao LL
PLoS One; 2015; 10(8):e0136670. PubMed ID: 26313461
[TBL] [Abstract][Full Text] [Related]
23. Pilot Study on the Utility of Circulating HER2/Neu Levels in the Serum of Breast Cancer Patients.
Morgan S; Amemiya Y; Slodkowska E; Lu FI; Parra-Herran C; Nofech-Mozes S; Trudeau M; Olkhov-Mitsel E; Seth A; Hanna WM
Anticancer Res; 2019 Oct; 39(10):5345-5352. PubMed ID: 31570428
[TBL] [Abstract][Full Text] [Related]
24. Prognostic factors of male breast cancer: A monocentric experience.
Ben Kridis W; Lajnef M; Bouattour F; Toumi N; Daoud J; Khanfir A
Breast Dis; 2023; 42(1):271-275. PubMed ID: 37638418
[TBL] [Abstract][Full Text] [Related]
25. Hormone Receptor-Positive Breast Cancer Has a Worse Prognosis in Male Than in Female Patients.
Li X; Yang J; Krishnamurti U; Huo L; Ward KC; O'Regan R; Peng L
Clin Breast Cancer; 2017 Aug; 17(5):356-366. PubMed ID: 28576631
[TBL] [Abstract][Full Text] [Related]
26. Time trends of overall survival among metastatic breast cancer patients in the real-life ESME cohort.
Gobbini E; Ezzalfani M; Dieras V; Bachelot T; Brain E; Debled M; Jacot W; Mouret-Reynier MA; Goncalves A; Dalenc F; Patsouris A; Ferrero JM; Levy C; Lorgis V; Vanlemmens L; Lefeuvre-Plesse C; Mathoulin-Pelissier S; Petit T; Uwer L; Jouannaud C; Leheurteur M; Lacroix-Triki M; Cleaud AL; Robain M; Courtinard C; Cailliot C; Perol D; Delaloge S
Eur J Cancer; 2018 Jun; 96():17-24. PubMed ID: 29660596
[TBL] [Abstract][Full Text] [Related]
27. Clinical and pathologic characteristics of BRCA-positive and BRCA-negative male breast cancer patients: results from a collaborative multicenter study in Italy.
Ottini L; Silvestri V; Rizzolo P; Falchetti M; Zanna I; Saieva C; Masala G; Bianchi S; Manoukian S; Barile M; Peterlongo P; Varesco L; Tommasi S; Russo A; Giannini G; Cortesi L; Viel A; Montagna M; Radice P; Palli D
Breast Cancer Res Treat; 2012 Jul; 134(1):411-8. PubMed ID: 22527108
[TBL] [Abstract][Full Text] [Related]
28. Treatment patterns, clinical outcomes, health resource utilization, and cost in patients with BRCA-mutated metastatic breast cancer treated in community oncology settings.
Houts AC; Olufade T; Shenolikar R; Walker MS; Schwartzberg LS
Cancer Treat Res Commun; 2019; 19():100121. PubMed ID: 30785027
[TBL] [Abstract][Full Text] [Related]
29. Prognostic Value of Modified IHC4 Score in Patients with Estrogen Receptor-Positive Metastatic Breast Cancer.
Jin L; Chen K; Tan C; Li J; Luo J; Yang Y; Li Y; Li S; Zhu L; Hu Y; Liu F; You Q; Peng M; Jiang Z; Liu Q
Oncologist; 2020 Aug; 25(8):e1170-e1180. PubMed ID: 32476192
[TBL] [Abstract][Full Text] [Related]
30. Utility of Oncotype DX in Male Breast Cancer Patients and Impact on Chemotherapy Administration: A Comparative Study with Female Patients.
Williams AD; McGreevy CM; Tchou JC; De La Cruz LM
Ann Surg Oncol; 2020 Oct; 27(10):3605-3611. PubMed ID: 32472417
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive Clinical Characterization of Decade-Long Survivors of Metastatic Breast Cancer.
Shin J; Kim JY; Oh JM; Lee JE; Kim SW; Nam SJ; Park W; Park YH; Ahn JS; Im YH
Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835414
[TBL] [Abstract][Full Text] [Related]
32. Male breast cancer: Outcome with adjuvant treatment.
Yadav BS; Sharma SC; Singh R; Dahiya D; Ghoshal S
J Cancer Res Ther; 2020; 16(6):1287-1293. PubMed ID: 33342786
[TBL] [Abstract][Full Text] [Related]
33. Comparison of Management and Outcomes in ERBB2-Low vs ERBB2-Zero Metastatic Breast Cancer in France.
de Calbiac O; Lusque A; Mailliez A; Bachelot T; Uwer L; Mouret-Reynier MA; Emile G; Jouannaud C; Gonçalves A; Patsouris A; Diéras V; Leheurteur M; Petit T; Cottu P; Ferrero JM; D'Hondt V; Desmoulins I; Mourato-Ribeiro J; Martin AL; Frenel JS
JAMA Netw Open; 2022 Sep; 5(9):e2231170. PubMed ID: 36107428
[TBL] [Abstract][Full Text] [Related]
34. Therapeutics targeting the metastatic breast cancer bone microenvironment.
Ihle CL; Wright-Hobart SJ; Owens P
Pharmacol Ther; 2022 Nov; 239():108280. PubMed ID: 36116682
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathologic Features and Radiation Therapy Utilization in Patients with Male Breast Cancer: A National Cancer Database Study.
Weir J; Zhao YD; Herman T; Algan Ö
Breast Cancer (Auckl); 2018; 12():1178223418770687. PubMed ID: 29881286
[TBL] [Abstract][Full Text] [Related]
36. Analysis of the distinct features of metastasis male breast cancer and its effect on overall survival based on the SEER database compared with female breast cancer.
Li H; Zhang Y; Teh MS; Limaye S; Cavalcante FP; Shen JB
Transl Cancer Res; 2023 Sep; 12(9):2371-2378. PubMed ID: 37859736
[TBL] [Abstract][Full Text] [Related]
37. Real-world clinical outcomes of patients with BRCA-mutated, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer: a CancerLinQ® study.
Miller RS; Mokiou S; Taylor A; Sun P; Baria K
Breast Cancer Res Treat; 2022 May; 193(1):83-94. PubMed ID: 35194731
[TBL] [Abstract][Full Text] [Related]
38. Male breast cancer in the veterans affairs population: a comparative analysis.
Nahleh ZA; Srikantiah R; Safa M; Jazieh AR; Muhleman A; Komrokji R
Cancer; 2007 Apr; 109(8):1471-7. PubMed ID: 17342768
[TBL] [Abstract][Full Text] [Related]
39. Metaplastic Breast Carcinoma: Clinicopathological Parameters and Prognostic Profile.
Haroon S; Zia S; Shirazi UA; Ahmed O; Asghar IA; Diwan MA; Afzal A; Irfan M; Ali SJ; Hashmi AA
Cureus; 2021 Apr; 13(4):e14347. PubMed ID: 33987039
[TBL] [Abstract][Full Text] [Related]
40. Clinical outcomes among HR+/HER2- metastatic breast cancer patients with multiple metastatic sites: a chart review study in the US.
Xie J; Hao Y; Li N; Lin PL; Ohashi E; Koo V; Wu EQ
Exp Hematol Oncol; 2015; 4():31. PubMed ID: 26693096
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
